IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup?

Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome

(2014) Emanuel Raschi et al.   Expert Opinion on Drug Metabolism & Toxicology

On the fiftieth anniversaryPostinfectious irritable bowel syndrome: mechanisms related to pathogens

(2014) M. Grover et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Intestinal Permeability Defects: Is It Time to Treat?

(2013) Matthew A. Odenwald et al.   Clinical Gastroenterology and Hepatology

Analysis of the Human Gut Microbiome and Association With Disease

(2013) Gary D. Wu et al.   Clinical Gastroenterology and Hepatology

Respondersvsclinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C

(2013) B. E. Lacy et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Intestinal microbiota in functional bowel disorders: a Rome foundation report

(2012) Magnus Simrén et al.   GUT

The burden and management of patients with IBS: results from a survey in Spanish gastroenterologists

(2012) Cristina Almansa et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Role of mucus layers in gut infection and inflammation

(2011) Gunnar C Hansson   CURRENT OPINION IN MICROBIOLOGY

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

(2011) Mirjana Rajilić–Stojanović et al.   GASTROENTEROLOGY

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

(2011) Ian B Jeffery et al.   GUT

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

(2010) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY